Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $110.0601 (-3.37%) ($110.0122 - $114.4364) on Thu. Mar. 15, 2018. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.55% (three month average) | RSI | 43 | Latest Price | $110.0601(-3.37%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ABBV declines -0.4% a day on average for past five trading days. | Weekly Trend | ABBV advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(50%) IVE(48%) SPLV(48%) IWD(47%) | Factors Impacting ABBV price | ABBV will decline at least -1.275% in a week (0% probabilities). VIXM(-16%) TLT(-14%) UUP(-10%) IGOV(-5%) DIA(-5%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.275% (StdDev 2.55%) | Hourly BBV | 0 () | Intraday Trend | -3.4% | | | |
|
Resistance Level | $112.2 | 5 Day Moving Average | $113.23(-2.8%) | 10 Day Moving Average | $111.93(-1.67%) | 20 Day Moving Average | $112.2(-1.91%) | To recent high | -6.7% | To recent low | 19.7% | Market Cap | $194.177b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |